It is a pleasure to serve under your chairship, Dr Huq.
“Women’s pain is too often dismissed, recorded as emotional, misunderstood and misdiagnosed. It’s got to change.”
Those are the words of my friend, Professor Geeta Nargund—an expert in women’s health, who joins us today. They sum up well the issues that we are here to talk about.
Ahead of today’s debate, the House of Commons put out a public call for evidence. We have been overwhelmed by more than 800 responses in just a few days, which shows the strength of feeling on this matter and how much women in this country want to see more focus on and prioritisation for women’s health.
Although I will focus my comments today on the state of women’s health in this country, it is worth putting on the record our concern for the awful situation that many women around the world find themselves in. I will never forget seeing the maternity theatre run by Save the Children in Yemen, where women gave birth between airstrikes. In many parts of the world, women struggle to access the most basic care and the most basic of reproductive rights and healthcare. The struggle for better women’s health does not stop at our borders.
We have heard stories from women up and down this country of not being believed, not getting diagnosed and then having difficulties obtaining treatment when they do finally get that diagnosis. Before coming on to some of the specific areas of women’s health that need to be addressed, I want to highlight the underlying themes that are too common in so many of these cases. For too long, women have had to fight to be believed and to be taken seriously, which can result in them losing their jobs. Their relationships, mental health and wellbeing can be affected. So many women have got in touch to share their stories of going through endless appointments and referrals in search of a diagnosis. During the long waits, women wait needlessly in pain and in huge suffering. For some, sadly, the long wait has proved fatal.
As this Labour Government take welcome action to tackle long gynaecological waiting lists, we are committed to improving inequalities in many areas of women’s health. It is worth pointing out that if we lined up the number of women currently stuck on the hugely long gynaecological waiting lists in this country, that line would stretch from London all the way to Exeter. What a shocking indictment of 14 years of Conservative failure!
In their submissions, several women shared their stories of having their symptoms dismissed by doctors or clinicians as being simply due to hormones, or even as having been imagined, only for the real diagnosis of a very serious rare cancer to come later on. I share one story of my friend—the late, great, Baroness Margaret McDonagh. Margaret attended her GP on several occasions complaining of painful headaches, but they were dismissed by her GP time and again as being related to her hormones. Tragically, Margaret was later diagnosed with a brain tumour, a glioblastoma. We all wish that it had been caught earlier; Margaret could still be with us today.
It is a pleasure to serve under your leadership, Dr Huq. I thank my hon. Friend the Member for Hastings and Rye (Helena Dollimore) for securing this important debate. As we have heard for far too long, women have been paying the price of an NHS that simply is not working. Women know that; in a survey that I saw, half of women said that they believed that their health was treated as second class.
Our economy is also paying the price. There are many areas that we could mention, but I want to focus on one in particular: the often very challenging journey that people experience when trying to have a baby. More than 3.5 million people in the UK go through some kind of fertility challenge, and that obviously has a huge impact on women. It can happen for a variety of reasons and is often heartbreaking. There is no one-size-fits-all approach to addressing fertility, but the National Institute for Health and Care Excellence guidelines are clear that, for women under 40 with a clinical diagnosis requiring in vitro fertilisation, or with unexplained infertility for two years, three NHS-funded cycles of IVF should be offered. The guidelines also recommend that women aged between 40 and 42 should be offered one cycle of IVF on the NHS, subject to some conditions.
Yet the reality is a postcode lottery. It is down to local integrated care boards to decide their approach, and only around a quarter of ICBs in England offer a full three cycles. The east of England, where my constituency is, has the lowest proportion of NHS-funded cycles, and my own ICB of Norfolk and Waveney offers two cycles. In other areas—north-east London, for example—the full three cycles are funded, whereas in areas such as Hampshire only one is.
Recent data tells us that fewer than 27% of IVF patients receive NHS funding nationally. When we think about our NHS, that is a huge anomaly. It means that most patients are paying for their treatment. Other factors also come into play: inequalities are stark when it comes to access and outcomes for black and ethnic minority patients, as well as for those in female same-sex relationships.
It is a pleasure to serve under your chairship, Dr Huq. I thank the hon. Member for Hastings and Rye (Helena Dollimore) for leading the debate and setting the scene incredibly well. I welcome the Minister to her place. I think this might be her first official engagement as Minister. If it is, I wish her well in her new role. I welcome the Conservative and Liberal Democrat spokespeople. The hon. Member for Hinckley and Bosworth (Dr Evans) and I seem to spend every Thursday afternoon at about this time in these debates. It is a pleasure to be here.
I am my party’s health spokesperson, so finding solutions and discussing these issues are of major importance to me. It is important to get the full perspective, so I will give some facts and figures about Northern Ireland, which will echo what the hon. Member for Hastings and Rye said.
Many will be aware that health is a devolved issue. That does not mean, of course, that our central Government allow the devolved Administrations to be left behind. The Department of Health back home launched a women’s health survey in late 2024. The hon. Lady referred to a similar survey. The Northern Ireland survey, which closed on 31 January 2025, focused on women’s healthcare needs and experiences to help shape planning for women’s health services. Almost 80% of respondents to a separate women’s health survey undertaken by the Community Foundation Northern Ireland said that they felt unheard by healthcare professionals, and more than 30% reported that necessary services were inaccessible or very inaccessible, so we have real problems back home.
I have worked closely alongside many charities raising awareness of endometriosis and polycystic ovary syndrome care, and the challenges that women in Northern Ireland face in relation to gaining access to treatment. Endometriosis UK revealed in 2023 that there was an average diagnostic delay of nine years and five months—an increase on the eight-year delay reported in 2010—so we really have significant issues in the Province.
It is a pleasure to serve under your chairmanship today, Dr Huq. I thank my hon. Friend the Member for Hastings and Rye (Helena Dollimore) for securing this important debate, and for her excellent opening speech. There are so many things that I want to talk about, but for time’s sake, I will focus my remarks around the importance of women being believed by healthcare professionals, and the detrimental effect on women when that is not the case.
The UK has the largest female health gap in the G20, and that is attributed in part to the misdiagnosis of conditions in women. It is absolutely shocking that eight in 10 women in this country report not being listened to by healthcare professionals.[Official Report, 4 June 2025; Vol. 768, c. 4WC.] (Correction) Those discrepancies extend beyond the confinement of the consulting room; they actively reinforce beliefs among wider society that women’s symptoms, no matter how debilitating, are normal. That is likely to prevent so many women from seeking medical advice, ultimately putting them at risk. Therefore, that widespread problem does not just perpetuate systemic misogyny but directly impacts women’s health outcomes and endangers their lives.
Published in August 2022, the 10-year women’s health strategy for England included a six-point plan on how to improve health outcomes and the way that the healthcare system listens to women. No. 1 on the list was to ensure that women’s voices are heard. In the month of the first anniversary of the publication of the excellent Hughes report, there is no better time to speak on an apt example of what happens when women’s voices are not heard. As the chair of the all-party parliamentary group on first do no harm, mesh, Primodos, valproate, I campaigned for justice and compensation on behalf of the thousands of women who live with the consequences every day of what happens when women’s voices are not listened to. The mesh scandal in particular exemplifies that perfectly.
It is a pleasure to serve under your chairship, Dr Huq. I congratulate the hon. Member for Hastings and Rye (Helena Dollimore) on securing this debate, which is one of only a handful to tackle women’s health in general. Since I came to this place, a big focus for me has been women’s health, whether it is the devastating and shocking findings of the Kirkup review of East Kent Hospitals maternity care; the setting up of the APPG for birth trauma; the plight of women who now have no recourse to any healthcare or medical treatment in Afghanistan; the women whose health and wellbeing means precisely nothing to the warring factions in places such as Tigray; the tenacious mothers who have tirelessly fought for changes to sodium valproate labelling; female cancers; vaginal mesh; menopause; the mental stress and health toll on WASPI—Women Against State Pension Inequality —or 1950s women; female genital mutilation; or domestic abuse survivors. All of those and so many more are health issues that affect the majority of the population, who are female. And for the avoidance of doubt, let me be clear: by female I mean women, adult human females, the kind who have a cervix and who definitely do not have a penis.
Despite women being 51% of the population, women’s health services are frequently deprioritised, with the healthcare model based on a default male, and women existing within a system built around men. The inequalities in health outcomes between men and women are scandalous. Compared with men, women are more likely to experience common mental health conditions, more likely to be misdiagnosed, more likely to receive less pain medication after identical procedures and more likely to be undertreated for pain by doctors.
A perfect example of how women must exist within a healthcare system built for men is that of heart attacks. I have recent experience of this, with my dear friend Nicky Clark experiencing a heart attack in January. She is now tirelessly campaigning, because compared with men, women are less likely to be admitted to hospital when they complain of chest pain and they have more than double the rate of death within 30 days following a heart attack. Medical professionals know that heart attacks present very differently in women, compared with men, and yet the classic symptoms listed in campaigns are specific to men only.
It is a pleasure to serve under your chairmanship, Dr Huq. I congratulate my hon. Friend the Member for Hastings and Rye (Helena Dollimore) on securing this important debate. Today, I want to talk about the stigma and embarrassment in relation to women’s incontinence: stress incontinence, urinary or faecal incontinence, and double incontinence. It affects so many aspects of women’s lives: where they go out, how much time they spend out, their relationships and their sleep patterns. And of course there are the effects on their mental and physical health.
Working as an NHS physiotherapist, I spoke to women about their incontinence when I did back screening, and I heard over and over again that women felt an overwhelming sense of shame—the fear of the smell, the sense of being dirty and the feeling of always having to check their pad to make sure that it is in place and has not leaked down their leg. It is estimated that a third of women in the UK are living with urinary incontinence. That means someone in this room will have those symptoms. A third of women suffer from a pelvic floor disorder after childbirth, including urinary incontinence and pelvic organ prolapse, but only 17% of women actually seek help. I would recommend to any woman who is suffering that she seek professional help from her GP or specialist. What we do not talk about for both faecal and urinary incontinence is the psychological problems, low self-esteem, anxiety, depression, sexual problems, social isolation, physical problems, skin breakdowns, and the falls when having to get to the toilet as quickly as possible.
At the moment, we also know there is an economic case that is also very compelling. Research shows that every £1 spent on women’s health services will return up to £13 back into our emergency services by reducing women going to A&E and GP appointments.
So what do I, as a clinician, propose? As a physiotherapist, of course I propose physiotherapy. Physiotherapy is the first line of intervention preventing mild to moderate incontinence and prolapse. It is therefore essential that we have women’s health physiotherapists in hubs locally as they are rolled out. We should also take a multifaceted approach to urinary and faecal incontinence, where women’s mental health, physical health, lifestyle—their caffeine and dietary intake—and the incontinence all get addressed. We should also make sure that, when people need the most help, referrals to secondary care or a surgeon are optimal.
It is a pleasure to serve under your chairmanship, Dr Huq. I thank the hon. Member for Hastings and Rye (Helena Dollimore) for bringing forward this very important debate.
The UK currently has the largest gender health gap in the G20 and the 12th largest in the world. It is high time that we focus on these disparities. Let me start with breast cancer. Breast cancer does not only affect women, of course, but the vast majority of cases are in women, with one woman being diagnosed with breast cancer every 10 minutes.
Over the last 20 years, the prognosis for women diagnosed with breast cancer has improved significantly. Women diagnosed with primary breast cancer today are 66% less likely to die from the disease within five years. That is encouraging news, but we cannot stop there.
Detecting breast cancer in its early stages drastically improves a woman’s chances of survival, but young women face huge challenges when it comes to being diagnosed. That is particularly harmful, because younger women are more likely not only to develop aggressive forms of the disease, but to be diagnosed at a later stage when the tumours are larger and have spread to the lymph nodes. As a result, younger women have a significantly worse prognosis, a higher risk of recurrence, and a greater chance of death compared with older women.
Even more alarmingly, cancer cases in women under 50 have increased by nearly 80% worldwide over the last 30 years. In the UK, breast cancer diagnoses in women under 50 have been steadily rising, and in 2013, we saw over 10,000 cases for the first time. Yet despite that growing trend, routine breast cancer screening still does not begin until women turn 50. Why do we start so late? It is an alarming trend and the Government must look at it. I know that the UK National Screening Committee advises on the decision about who to screen, and I have been assured that it will be looked into, but I mention it today to urge the Government to make progress.
My constituent, a GP, got in contact after she recently had to cut specialised contraception services in her practice due to national insurance hikes and inadequate funding. The services were running at a loss, making them unsustainable. Does my hon. Friend agree that that lack of funding is short-sighted and will harm health outcomes, and that all women should have equitable access to contraception?
20 of 55 shown
Anyone who knew Margaret will be aware of what a force of nature she was. It shows the scale of the issues facing women in accessing healthcare that even she was dismissed. We have heard similar stories from women eventually diagnosed with ovarian cancer and blood cancer, with the delayed diagnosis damaging their chance of successful curative treatment.
Many women eventually diagnosed with endometriosis shared similar stories. In its 2024 report of over 4,000 women who had received a diagnosis, the charity Endometriosis UK found that almost half of the women had visited their GP 10 or more times before receiving a diagnosis. Some 70% had visited over five times and 20% reported seeing a gynaecologist 10 or more times before getting a diagnosis.
Another common barrier for women is the lack of research and data about women’s health. We have all been made familiar with the gender data gap and the consequences for policymaking by Caroline Criado Perez’s excellent book “Invisible Women”. The gender health gap is stark. The Women and Equalities Committee report published in December said:
“past research has shown that five times more research is conducted into erectile dysfunction than premenstrual syndrome. This is staggering considering that 19% of men are affected by erectile dysfunction, while 90% of women have premenstrual syndrome.”
Over-the-counter Viagra was available a full six years before chemists in this country were able to provide medicine over the counter for urinary tract infections.
It is clear that far more attention and focus needs to be given to women’s menstrual cycles and treatment for conditions related to them, including the menopause. Why is it that in over a decade of being at school in this country, I learned all about many obscure topics like oxbow lakes, but never about the menopause, which affects 51% of our population? Everyone will be affected by it, whether they experience it as a woman or their mother, daughter or wife does.
We are rightly seeing more focus given to the menopause thanks to the work of many campaigners. I want to give particular mention to my hon. Friend the Member for Neath and Swansea East (Carolyn Harris) for her championing of the cause. She and many others have rightly highlighted the shocking delays for women in accessing hormone replacement therapy treatment— a medicine that plays a critical role in alleviating the symptoms of the menopause, helping millions of women in the UK manage what is a natural life transition.
One of my constituents, Kate, wrote to me to describe her struggle to access adequate treatment for the pain that she has been suffering and how she was not taken seriously by medical professionals. She says:
“At one point, I was experiencing such a high level of pain…that I was sent by the GP to A&E with suspected appendicitis. After tests confirmed what I’d said all along”—
that it was endometriosis—
“I was ‘confronted’ by a doctor…who demanded to know why I was there, and what I thought they should do to help me. When I said that I’d been clear that I thought it was related to endometriosis the whole time, she dismissed me and said ‘we don’t deal with menstrual issues in A&E’. I left in tears and pain and have since avoided A&E despite experiencing acute pain”.
Another area of great importance in this debate is maternity services. I recently had the chance to visit my local maternity unit at the Conquest hospital in Hastings and see the fantastic care that local midwives are giving women. Midwives are working really hard and have our full support. We need to ensure that we are doing everything we can to tackle the retention crisis in midwifery and encourage more young people to enter the profession. We have heard harrowing evidence in the numerous reviews commissioned into maternity services at a number of hospital trusts of the same mistakes being made over and over again and lessons not being learned, with tragic consequences of women and babies losing their lives or experiencing traumatic births. That has to change.
The landmark report of the all-party parliamentary group on birth trauma in the previous Parliament set out for the first time the shocking impact that traumatic births have had on women and their families and what needs to change to prevent that. Often, those tragic cases were a result of an unhealthy obsession in maternity units with not intervening. I must point out to the House how damaging that obsession has been for many women. The report made many important recommendations and I hope that the Government will look closely at them.
I pay tribute to those in that all-party group in the previous Parliament for the work that went into that report and to the women who shared their stories, and to all the women that have shared their stories as part of the House of Commons call for evidence. We have looked through all of them, and I know that many Members will be sharing stories about their own constituents’ experiences.
It is also worth pointing out that some examples of brilliant women’s healthcare have been shared as well. I want to particularly mention Dr Warner from the Rye medical centre in my constituency. She was mentioned by a number of women who got in touch with me who said she was a champion of women’s healthcare; as a result, a huge waiting list of women were waiting for appointments with her because word of mouth had spread about how she prioritised this issue.
Maternity services, of course, are not the only area in which shocking scandals have been exposed regarding women’s health. We will hear today from Members who have been campaigning for justice for the women who were victims of the mesh and sodium valproate scandals. We have also heard a number of shocking stories from women, as part of their submissions, about an inability to access basic contraception, about long waits to access the healthcare that they have the right to access and about challenges in women’s mental health services.
Many Members wish to speak, so I will sum up by saying that it is clear that far more attention needs to be given to women’s health. I am looking forward to hearing the stories from other Members’ constituencies and how this Labour Government will be working to ensure that women get the support and treatment that they have the right to.
The postcode lottery needs to end. We must address those inequalities in access to NHS funding. There also needs to be greater education for healthcare professionals around fertility, regarding diagnosis and treatment, and for people themselves, so that patients have the choice and know what to do when it comes to their own fertility.
Beyond medical treatment, there is also not enough support in the workplace. We really need a whole-of-Government approach to this issue. It is not just about the Department of Health and Social Care; there are so many other areas, including, importantly, the Department for Work and Pensions. There is no legal right to time off for fertility treatment and currently, under the Equality and Human Rights Commission’s code of practice, fertility treatment is compared with cosmetic dental surgery. That means that many employers regard fertility treatment as a “nice to have”—an elective choice. Instead, it should be treated as a medical procedure that is needed.
I have heard stories of women losing their jobs simply because they have attended an IVF appointment. That needs to change. That is why I am campaigning, with Fertility Matters at Work and others, for a change in the law, so that people—women, in particular—have a right to paid time off for fertility treatment. I have met the Minister for Employment, my hon. Friend the Member for Birkenhead (Alison McGovern), to discuss the issue, and I welcome the continued engagement with the Government. I hope the Minister will meet us to discuss those demands. Many companies, including Centrica, E.ON and Cadent, already give women time off because they know it makes sense for productivity and happiness at work. Almost one in five people undergoing fertility treatment end up leaving their jobs because of the impact.
I also want to touch on miscarriage, another aspect of the journey; I know that my hon. Friend the Member for Walthamstow (Ms Creasy) will mention it as well. We need a right to time off for miscarriage before 24 weeks. It causes huge trauma, and women do not recover from it straight away. They need to be given time.
In the 30 seconds that I have left, I want to touch on gynaecology in my area of Norfolk. The situation is dire: we have the worst wait for gynaecology treatment in England. We are nowhere near the 92% target of 18 weeks: the figure is 44% in Norfolk and Waveney. Research from the House of Commons Library shows that more than 1,000 patients have been waiting for more than a year in Norfolk and Waveney, and that has a massive impact on women’s health.
I have to stop there. I wanted to talk about women’s health hubs, but I am sure that others will. There are so many issues to discuss, but when it comes to fertility and gynaecology, we simply cannot wait. Our manifesto promised that we will not neglect women’s health again, and I am sure that we will live up to that promise.
As of 2021, Northern Ireland had only one endometriosis specialist surgeon, and some 324 women were waiting a long time, in pain, for surgery. I ask the Minister whether it would be possible for her to have some discussions with the relevant Minister in the Northern Ireland Assembly to see how we can address these things together.
I want to speak very quickly about the menopause. The hon. Member for Neath and Swansea East (Carolyn Harris), who is not here—she is in the main Chamber speaking on St David’s day—is a real champion on this issue. If she were here today, she would be adding to this debate. In my office, I employ six women of different ages, and I have always tried to make an effort to be understanding to ensure they are comfortable in the workplace. For menopause, there are adjustments that can be made in the workplace to support women, and I encourage employers to be mindful of that, especially in more male-dominated fields, where women can feel more isolated. Women are playing their part in places where men used to have all the jobs, such as engineering. It is time that employers grasped that and came up with something to help those ladies.
I have mentioned some of the issues, but there are many, many more. As the hon. Member for Hastings and Rye said, we in this place can do more as legislators to support more research into and funding for women’s healthcare. We need to do more to ensure women can access what they need. I look forward to working closely with the responsible agencies and our respective Governments to see what more can be done. I thank the hon. Lady again for bringing forward this debate, and I look forward to contributions from many others who will add to it. I am here to help us do the best we can, and to bring a Northern Ireland perspective, because we are badly lagging behind. We need to step up and do more.
To set the scene, it is believed that 40,000 women in this country could be affected by mesh damage and complications, and 10,000 of those women have been left with disabilities, as the mesh has cut into their organs and nerves. I hear from mesh-impacted constituents who describe desperate situations of poverty, depression and isolation as a result. Many have lost their jobs, their marriages and their trust in a service that is supposed to be there for us when we are sick, not make us sick.
Perhaps even worse was the treatment of those women when they realised that it was the mesh that was causing their health complications. The women then report being gaslit, undermined and ridiculed when trying to sort out a mess they had no part in making, or even consenting to in most cases. Among the thousands of mesh-injured women is my own mam. I personally sat next to her at our local hospital and watched her be gaslit and undermined by her original surgeon when she first sought help with her pain and symptoms. Despite now having had her mesh removed by the wonderful Dr Suzy Elneil in London, the complications sadly do not stop there.
The way mesh attaches to our organs has been likened to the way that chewing gum gets caught in our hair, so it is almost impossible to fully remove it. As such, regardless of the removal, my mam, now 80, is still struggling and in her own words, will never be the same again. The important point is that had my mam and the thousands of others affected been men suffering horrendous pain as a result of a medical procedure, I do not believe that dismissal on such a scale would have occurred. Nor do I believe that compensation and recognition of the scandal would be such a painfully slow process.
Before I finish, I put on record my gratitude to my friend who recently retired from the other place, Baroness Cumberlege, for all her work on this issue. I will leave it there, as I am out of time.
Recent trends in the collection of data highlight how vital the accurate recording of this is in a medical context. Women’s health issues all arise from our specific biology. A man cannot get ovarian cancer and a woman cannot get prostate cancer, for example. It may be considered good manners, kind and courteous to refer to those who identify as a different gender in the way they prefer, but for the specific purposes of recording vital and potentially lifesaving data, we must accurately record patients’ biological sex. Otherwise, trans patients may miss being called for screening for sex-specific conditions, and that has potentially fatal consequences. That has been highlighted by Professor Alice Sullivan, who was commissioned by the last Government to tackle the issue of recording sex data, including in the NHS. Her review is due to be published, and I would be grateful if the Government could confirm the date for that as soon as possible.
In the last seven years, we have had seven Secretaries of State for Health and Social Care. It is very hard to get even on the second rung of a ladder when we have to start all over again with explanations, evidence and examples relating to a campaign or specific health issue every few months because the departmental personnel and teams change so often, so women here will keep campaigning and holding debates to push women’s health further up the agenda. I will keep working with the Birth Trauma Association, the MASIC Foundation and others to help to end the postcode lottery and extreme inequalities for black and south Asian mothers experiencing what should be straightforward and perfectly safe childbirth. I again thank all those parliamentarians, campaigners and activists who just will not take no for an answer and who fight every day to bring about better experiences for other women.
We also need to get the first line of treatment for incontinence on to our high streets, making it more accessible for women to get self-referrals as quickly as possible. We should not have a barrier to speaking to a healthcare professional or a GP; women should be able to go into a high street pharmacist and say, “I’ve got incontinence. What can be done to help?” I welcome the Government’s steps for women’s health hubs, but we need to go further by making sure that there is a national campaign so that women know that those hubs exist.
I say to the women listening to this Westminster Hall debate: you are not alone and there is no shame. As a nation, we cannot allow women to feel shame or embarrassment about this topic any longer. Incontinence is common, so will my hon. Members join me in my mission to break the silence, end the stigma and eliminate the anxiety around incontinence?
Another issue affecting many women in Bath is gynaecological care. A new report from the Royal College of Obstetricians and Gynaecologists said the UK has a “gynaecology care crisis”, with over 750,000 patients currently waiting for treatment for a serious condition.